Top Markets
Coin of the day
CinCor Pharma, Inc. CinCor Pharma, Inc.

CinCor Pharma, Inc.

CINC
Peringkat dalam Saham #11594
CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical... CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical development phase, dedicated to pioneering therapeutic solutions for cardiovascular and renal conditions. At the core of its pipeline is CIN-107, an investigational compound currently undergoing Phase II clinical trials for indications such as hypertension, primary aldosteronism, and various other cardio-renal disorders. Additionally, CIN-107 is in Phase I clinical evaluation for its potential in treating chronic kidney diseases. The company holds a significant licensing agreement with F. Hoffman-La Roche Ltd. and Hoffmann-La Roche Inc. Established in 2018, CinCor Pharma, Inc. maintains its principal operations in Boston, Massachusetts.
Harga Saham
$29.06
Terakhir disinkronkan: 2023-02-23
Kapitalisasi Pasar
$682.73M
Perubahan (1 hari)
-0.48%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan CinCor Pharma, Inc. (CINC)

Kategori

Riwayat pemecahan saham untuk CinCor Pharma, Inc. (CINC)
Saham CinCor Pharma, Inc. (simbol: CINC) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Aug 30, 2026.
Satu lembar saham CINC yang dibeli sebelum Aug 30, 2026 sekarang setara dengan 0 lembar saham CINC.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
Tidak cukup data untuk tanggal yang disediakan.
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH